Junichi Takagi at IPI Surfacing: The “Lasso-grafted” Fc design platform offers creation of novel receptor agonists and antagonists
Junichi Takagi speaks at IPI Surfacing, a symposium on cell surface receptor biology and protein…
Christopher Garcia at IPI Surfacing: Modulating cell physiology through ligand-receptor engineering
Christopher Garcia speaks at IPI Surfacing, a symposium on cell surface receptor biology and protein…
IPI Surfacing panel discussion: The promise of synthetic antibodies and the challenges to universal access
The IPI Surfacing panel discusses the biomedical applications of synthetic antibodies, barriers to competing with…
At IPI Surfacing, panel calls for long-overdue collaboration to improve antibody reliability and accessibility
In a perfect world, antibody reagents would be reliable. Their protein sequences would be accessible.…
IPI broadens scientific expertise with new talent
In 2022, IPI successfully broadened its expertise and streamlined its pipeline by bringing in new…
From president and CEO Ken Fasman: IPI in the midst of an exciting growth year
I joined the Institute for Protein Innovation in November 2022, coming from a long term…
The Institute for Protein Innovation and Addgene partner to accelerate biomedical discovery with the development and distribution of protein-binding reagents
Partnership joins two nonprofits with aligned missions to provide researchers with access to well-validated antibodies…
IPI starts new chapter with game-changing gift: A Q&A with Tim Springer
Big philanthropic gifts can be powerful vehicles of transformation for any young organization. With a…
Harvard professor and entrepreneur Tim Springer donates $210 million to the Institute for Protein Innovation
The gift further positions the emerging nonprofit to transform biomedical research with novel protein tools…
Sophia Ulmer brings creativity and computational prowess to protein engineering
Art and science can seem at odds. But fundamentally, both focus on exploration and the…
Chasing a ‘quantum leap’ in cell surface biology: A Q&A with Junichi Takagi
Cell surface receptors are, by and large, the main molecular target for therapeutics. Also known…
Institute for Protein Innovation welcomes top researchers at first symposium
BOSTON, March 29, 2023 — The Institute for Protein Innovation (IPI) will host IPI Surfacing,…